Cargando…

The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study

OBJECTIVE: Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population...

Descripción completa

Detalles Bibliográficos
Autores principales: Amouzegar, Atieh, Gharibzadeh, Safoora, Kazemian, Elham, Mehran, Ladan, Tohidi, Maryam, Azizi, Fereidoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215694/
https://www.ncbi.nlm.nih.gov/pubmed/28052092
http://dx.doi.org/10.1371/journal.pone.0169283
_version_ 1782491803825471488
author Amouzegar, Atieh
Gharibzadeh, Safoora
Kazemian, Elham
Mehran, Ladan
Tohidi, Maryam
Azizi, Fereidoun
author_facet Amouzegar, Atieh
Gharibzadeh, Safoora
Kazemian, Elham
Mehran, Ladan
Tohidi, Maryam
Azizi, Fereidoun
author_sort Amouzegar, Atieh
collection PubMed
description OBJECTIVE: Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population based study. MATERIAL AND METHODS: This prospective study was conducted within the framework of the Tehran Thyroid Study (TTS) on 5783 (2376 men and 3407 women) individuals aged ≥ 20 years who had thyroid function tests at baseline and were followed up for median 9.1 year with TPOAb measurements at approximately every 3 years. RESULTS: The mean age of total population at baseline was 40.04±14.32. At baseline, of the 5783 participants, 742 (12.8%) were TPOAb positive, with higher prevalence among women than in men (16.0 vs. 8.5%, p = 0.001). The prevalence of TPOAb positivity in the total population was 11.9, 14.9 and 13.6% in the young, middle age and elderly respectively. The total incidence rate (95%CI) of TPOAb positivity in the total population (5020) was 7.1 (6.36–7.98) per 1000 person-years of follow-up, with higher incidence of TPOAb positivity among young participants, i.e. 8.5 (7.5–9.7) per 1000 person-years. Sex specific incidence rate demonstrated that TPOAb positivity was higher in women, 9.3 (8.2–10.7) per 1000 person-years. The Cox's proportional hazard model analysis showed that the hazard ratio of developing TPOAb positivity was higher in women than men (P<0.0001) and tended to increase slightly with serum TSH levels (P<0.0001) but declined with increasing age (P<0.0001) in the total population. Our findings demonstrate that individuals, who became TPOAb positive in each phase, had significant elevation of TSH levels at the phase of seroconversion, compared to baseline values. CONCLUSION: Gender, age and elevated serum TSH were found to be risk factors for developing TPOAb positivity. Furthermore, compared to baseline a significant elevation of TSH levels during seroconversion phase was observed in TPOAb positive individuals.
format Online
Article
Text
id pubmed-5215694
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52156942017-01-19 The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study Amouzegar, Atieh Gharibzadeh, Safoora Kazemian, Elham Mehran, Ladan Tohidi, Maryam Azizi, Fereidoun PLoS One Research Article OBJECTIVE: Thyroid peroxidase antibody (TPOAb), the most common antibody frequently measured in population surveys is a protein expressed in the thyroid gland. We conducted the present study to analyze the prevalence and incidence of thyroid auto immunity and natural course of TPOAb in a population based study. MATERIAL AND METHODS: This prospective study was conducted within the framework of the Tehran Thyroid Study (TTS) on 5783 (2376 men and 3407 women) individuals aged ≥ 20 years who had thyroid function tests at baseline and were followed up for median 9.1 year with TPOAb measurements at approximately every 3 years. RESULTS: The mean age of total population at baseline was 40.04±14.32. At baseline, of the 5783 participants, 742 (12.8%) were TPOAb positive, with higher prevalence among women than in men (16.0 vs. 8.5%, p = 0.001). The prevalence of TPOAb positivity in the total population was 11.9, 14.9 and 13.6% in the young, middle age and elderly respectively. The total incidence rate (95%CI) of TPOAb positivity in the total population (5020) was 7.1 (6.36–7.98) per 1000 person-years of follow-up, with higher incidence of TPOAb positivity among young participants, i.e. 8.5 (7.5–9.7) per 1000 person-years. Sex specific incidence rate demonstrated that TPOAb positivity was higher in women, 9.3 (8.2–10.7) per 1000 person-years. The Cox's proportional hazard model analysis showed that the hazard ratio of developing TPOAb positivity was higher in women than men (P<0.0001) and tended to increase slightly with serum TSH levels (P<0.0001) but declined with increasing age (P<0.0001) in the total population. Our findings demonstrate that individuals, who became TPOAb positive in each phase, had significant elevation of TSH levels at the phase of seroconversion, compared to baseline values. CONCLUSION: Gender, age and elevated serum TSH were found to be risk factors for developing TPOAb positivity. Furthermore, compared to baseline a significant elevation of TSH levels during seroconversion phase was observed in TPOAb positive individuals. Public Library of Science 2017-01-04 /pmc/articles/PMC5215694/ /pubmed/28052092 http://dx.doi.org/10.1371/journal.pone.0169283 Text en © 2017 Amouzegar et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Amouzegar, Atieh
Gharibzadeh, Safoora
Kazemian, Elham
Mehran, Ladan
Tohidi, Maryam
Azizi, Fereidoun
The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
title The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
title_full The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
title_fullStr The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
title_full_unstemmed The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
title_short The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study
title_sort prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: tehran thyroid study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215694/
https://www.ncbi.nlm.nih.gov/pubmed/28052092
http://dx.doi.org/10.1371/journal.pone.0169283
work_keys_str_mv AT amouzegaratieh theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT gharibzadehsafoora theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT kazemianelham theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT mehranladan theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT tohidimaryam theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT azizifereidoun theprevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT amouzegaratieh prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT gharibzadehsafoora prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT kazemianelham prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT mehranladan prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT tohidimaryam prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy
AT azizifereidoun prevalenceincidenceandnaturalcourseofpositiveantithyroperoxidaseantibodiesinapopulationbasedstudytehranthyroidstudy